Treatment of HIV Infection: Strategies, New Drugs and Drug Metabolism
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 17
Special Issue Editor
Interests: HIV; hepatitis; infectious diseases; HBV; HDV; HCV; dyslipidemia; steatosis; atheromatous plaques
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
HIV is one of the most important infectious diseases due to its clinical and sociological implications, as patients still face stigma, and its wide diffusion, despite long-standing awareness and prevention campaigns. Research has made many advancements to improve not only treatment effectiveness but also patient quality of life. Nowadays, therapies are based on single-tablet regimens, reducing the pill burden. Additionally, there is also the revolutionary possibility of resorting to long-acting injection therapy, administered every two months. In fact, this could guarantee patients greater freedom around therapy, avoiding taking daily drugs, which could further translate, for some, into logistical and sometimes psychological advantages. This Special Issue aims to analyze the effect of this type of regimen on patients in terms of efficacy and metabolism.
Dr. Salvatore Martini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV
- long-acting
- efficacy
- tolerability
- adherence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
